Day: December 5, 2022
Chicago, Dec. 05, 2022 (GLOBE NEWSWIRE) — Aircraft Tires Market by Type (Radial-ply and Bias-ply), Aircraft Type (Business and General Aviation, Commercial Aviation, Military Aviation), Platform (Fixed-wing and Rotary-wing aircraft), Position, End-User, and Region – Global Forecast to 2027″, Aerospace Manufacturers are developing enhanced Aircraft Tires that are fuel-efficient and durable. There is the adoption of sustainable Aircraft Tires systems, which are environment friendly and have reduced carbon emissions while providing an optimal tread life.
Ask for PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=163712012
Aircraft Tires Market Report Scope:Report Metric
DetailsMarket Size Value in 2022
USD 1.4 BillionRevenue Forecast in 2027
USD 1.6 BillionGrowth Rate
2.9%...
Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with Kineta
Written by Customer Service on . Posted in Dividend Reports And Estimates.
Special dividend estimated to be in range of $1.34 to $1.43 per share
Payment of special dividend conditioned upon closing of both Asset Sale and Merger, which are subject to stockholder approval
BOSTON, Dec. 05, 2022 (GLOBE NEWSWIRE) — Yumanity Therapeutics, Inc. (“Yumanity” or the “Company”) (Nasdaq: YMTX) announced today that its Board of Directors has declared a special dividend in connection with the previously announced asset sale to Janssen Pharmaceutica NV (“Janssen”) and merger with Kineta, Inc. (“Kineta”).
The special dividend, which the Company estimates will be in range of $1.34 to $1.43 per share of Yumanity common stock, will be payable in cash on or before December 29, 2022, to stockholders of record at the close of business on December 15, 2022. The special dividend will be equal to the gross proceeds of the asset...
Gelatin Market to Hit USD 4.42 Billion by 2029 | At a CAGR of 6.43 %
Written by Customer Service on . Posted in Mergers And Acquisitions.
Companies covered in gelatin market are Gelita AG (Germany), Darling Ingredients Inc. (U.S.), Nitta Gelatin, Inc. (Japan), Tessenderlo Group (Belgium), Weishardt (France), Trobas Gelatine B.V. (Netherlands), Lapi Gelatine S.p.a. (Italy), Juncà Gelatines SL (Spain), Italgel S.r.l (Italy), Sterling Biotech Ltd. (India), Gelnex (Brazil) & more.
Pune, India, Dec. 05, 2022 (GLOBE NEWSWIRE) — The global gelatin market size was valued at USD 2.65 billion in 2021. The market is projected to grow from USD 2.86 billion in 2022 to USD 4.42 billion by 2029, exhibiting a CAGR of 6.43% during the forecast period.
This information is provided by Fortune Business Insights, in its report titled, “Gelatin Market, 2022-2029.”
Get a Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/gelatin-market-107012
List...
Aircraft Hangar Market to Worth USD 1,000.6 Million by 2029 | Fortune Business Insights™
Written by Customer Service on . Posted in Mergers And Acquisitions.
According to Fortune Business Insights™, the global aircraft hangar market size is projected to reach USD 1,000.6 Million by 2029, at CAGR of 4.81% during forecast period 2022-2029
Pune, India, Dec. 05, 2022 (GLOBE NEWSWIRE) — The global aircraft hangar market size stood at USD 703.0 million in 2021. The market value is slated to rise from USD 720.3 million in 2022 to USD 1,000.6 million by 2029 at a CAGR of 4.81% during 2022-2029. Hangars can be either fixed or moveable in construction. As they are simple to install, take less time to set up, and are less expensive, inflatable portable hangars are becoming more and more popular. Fortune Business Insights™ presents this information in its report titled, “Global Aircraft Hangar Market, 2022-2028”.
Get a Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/aircraft-hangar-market-103514
List...
AnPac Announces Strategic Initiative to Establish A Wholly-Owned Subsidiary for US Food Market
Written by Customer Service on . Posted in Public Companies.
PHILADELPHIA, Dec. 05, 2022 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (Nasdaq: ANPC) (“AnPac Bio” or the “Company”), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, today announced that the Company has formed a wholly-owned subsidiary Fresh2 Technology Inc in the State of Delaware on October 4, 2022 in order to establish the company’s new product line of business-to-business food trade and delivery platform for local restaurants and supermarkets, a combination of the China’s food distribution strategies and North America’s growing Asian food market.
Mr. Haohan Xu, the Co-CEO commented: “We are dedicated to developing and producing high-performance platform and supply chain of food distribution system, for a broader client group in US local...
Aridis Signs Exclusive Terms to Secure Worldwide Commercial Licenses for Pan-Ebola and Pan-Marburg Monoclonal Antibody Programs from Mapp Biopharmaceutical
Written by Customer Service on . Posted in Public Companies.
The Sudan Ebola and Marburg mAb programs were awarded approximately $190 million of BARDA funding covering manufacturing, efficacy and safety evaluations, and regulatory approvalLos Gatos, Calif., Dec. 05, 2022 (GLOBE NEWSWIRE) — Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating life-threatening infections, signed an exclusive term sheet to secure international development and global commercial rights upon licensure for the pan-Ebola and pan-Marburg monoclonal antibody (mAbs) programs from Mapp Biopharmaceutical, Inc. (MappBio), a privately-owned leading developer of novel pharmaceuticals for the prevention and treatment of infectious diseases with a focus on unmet needs in global health and biodefense.Aridis and...
The Centers for Medicare & Medicaid Services Makes Preliminary Recommendation to Establish New HCPCS Billing Code Dedicated to Arch Therapeutics’ AC5® Advanced Wound System
Written by Customer Service on . Posted in Public Companies.
A dedicated code would represent a key milestone for commercialization of AC5 Advanced Wound System in doctors’ offices and other outpatient settings
FRAMINGHAM, Mass., Dec. 05, 2022 (GLOBE NEWSWIRE) — Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical products, today announced that the Centers for Medicare and Medicaid Services (“CMS”) has made a preliminary recommendation to establish a dedicated Healthcare Common Procedure Coding System (“HCPCS”) Level II billing code specific to AC5® Advanced Wound System (“AC5”). The preliminary recommendation was discussed at CMS’ First Biannual 2022 HCPCS Public Meeting, which was held on November 30, 2022. The HCPCS code would better enable providers to bill third party payors for AC5 that is used...
Selection of candidates for independent Audit Committee member and Remuneration and Nomination Committee member of AB Klaipėdos nafta is announced
Written by Customer Service on . Posted in Public Companies.
On 5th August, 2022, AB Klaipėdos nafta (hereinafter – the Company), announced a selection of candidates for independent members of the Audit Committee and Remuneration and Nomination Committee under Supervisory Council (hereinafter – Committees) of the Company.
The selection is announced for one independent member of the Audit Committee of the Company and for one independent member of the Remuneration and Nomination Committee of the Company.
The selection shall be performed according to the Schedule for the selection of independent members of the Audit Committee and Remuneration and Nomination Committee of AB Klaipėdos nafta, approved by the 24th November, 2022 decision of the Supervisory Council of the Company. After the selection procedures are performed, the members of the Committees shall be elected by the Supervisory Council of the...
Form 8.3 – [Devro plc – 02 12 2022] – (CGWL)
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION(a) Full name of discloser:
CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree
DEVRO PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
N/A(e) Date position held/dealing...
Lilium expands into UK market with eVolare, signs binding contract including pre-delivery payment for up to 20 aircraft
Written by Customer Service on . Posted in Public Companies.
Lilium expands into UK market with eVolare and the Lilium Pioneer Edition
The Lilium Pioneer Edition, which formally launches today, is a 50 aircraft limited-edition exclusive version of the Lilium Jet. Find out more: Link to press release #Lilium #eVTOLeVolare secures deliveries of ten Lilium Pioneer Edition Jets with an option to reserve up to an additional ten Lilium Pioneer Edition Jets
eVolare to serve the Greater London area from its Oxford base
eVolare to pay pre-delivery payment to Lilium to secure aircraft delivery slots
The order coincides with the formal launch of the Lilium Pioneer Edition, a 50 aircraft limited-edition exclusive version of the Lilium JetOXFORD, United Kingdom and MUNICH, Germany, Dec. 05, 2022 (GLOBE NEWSWIRE) — Lilium N.V. (NASDAQ: LILM), developer of the first all-electric vertical take-off...